(Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that new EQ504 preclinical data have been accepted for poster ...

Hallux Announces Poster Exhibit Abstract ID 74740 on Dermatophytoma Treatment by HSG 42 in Phase 2a trial Available for ...

When 21-year-old Cooper Tidwell, a junior studying art at the University of Arkansas, first heard about Act 573, it felt too ...

The South Korean spatial biology company unveils new AI agents, foundation models, and spatial biomarkers for oncology drug discovery. SEOUL, South Korea, /PRNewswire/ -- Portrai, Inc. today announced ...

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that the company will present seven abstracts, including two oral sessions, at the American Association for ...

Civic election campaign posters aren’t usually considered works of art.

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that the company will present seven abstracts, including two oral sessions, ...

Amarin Corporation plc (NASDAQ: AMRN) ("Amarin"), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today highlighted the important scientific and educational ...

Natera, Inc. (NASDAQ: NTRA) a global leader in cell-free DNA and precision medicine, today announced that 20 abstracts, including two oral presentations, featuring data generated using its ...

Boise State’s Department of Chemistry and Biochemistry will host the 79th Northwest Regional Meeting for the Snake River Section of the American Chemical Society in summer 2026, from July 28 to July 1 ...

At AACR 2026, Insilico will unveil four novel cancer inhibitors discovered via its end-to-end Pharma.AI platform. By harnessing trillions of data points and millions of molecular fragments, the ...

Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today ...